Sonenco Overview

  • Founded
  • 2003
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 3

Sonenco General Information


Developer of ultrasonic catheters designed to conduct brain cancer therapy. The company's catheters referred to as Sonoguide are used to execute the delivery of medication-coated nano-particles to specific organs and tissues in the body, enabling medical professionals to acquire a novel method of delivering those drugs to the brain that are usually blocked from making entry by the blood brain barrier.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Other Industries
Therapeutic Devices
Primary Office
  • Granot Intiative Center
  • Hefer 38100
  • Israel
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sonenco Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator Completed Startup
1. Later Stage VC 10-Apr-2011 Completed Startup
To view Sonenco’s complete valuation and funding history, request access »

Sonenco Executive Team (1)

Name Title Board Seat Contact Info
Dan Levi Chief Executive Officer
To view Sonenco’s complete executive team members history, request access »

Sonenco Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Granot Ventures Venture Capital Minority 000 0000 000000 0
Meizam Arad Corporation Minority 000 0000 000000 0
Yozmot HaEmek Accelerator/Incubator 000 0000 000000 0
To view Sonenco’s complete investors history, request access »